As part of our quality improvement program we are enrolled in Radiation Oncology Incident Learning System (RO-ILS) . RO-ILS is a national database sponsored by ASTRO and the AAPM and dedicated to improving patient safety by collecting and analyzing treatment-related incidents. This has been a part of the CQI program since 2017.
Peer review in radiation oncology is a vital component to ensure patient safety and accurate treatment delivery, especially as the complexity of radiation treatments continues to increase. Weekly meetings are held to review patient’s treatment plans.
The daily morning huddle gives our team a way to actively manage quality and safety, review checklists, improve inter-department coordination, and flag concerns proactively. Huddles provide a venue to ensure process improvements sticks.
Another way that we continuously strive to improve the quality of cancer care for patients is the Michigan Radiation Oncology Quality Consortium (MROQC). MROQC is a statewide quality initiative coordinated by members of our department. In addition to gathering clinical data, key dosimetry and physics data are similarly collected in a registry for eligible breast and lung cancer patients. https://medicine.umich.edu/dept/radonc/major-initiatives/mroqc
Genesys Hurley Cancer Institute (GHCI) is a component site of Michigan Cancer Research Consortium (MCRC) NCORP led by St. Joseph Mercy Hospital, Ann Arbor, Michigan. MCRC is one of only 34 community-based research programs supported by the National Cancer Institute (NCI).
Our facility has voluntarily gone through a rigorous review process to ensure that we meet nationally-accepted standards of care. Our equipment is appropriate for the treatment you will receive, and our facility meets or exceeds quality assurance and safety guidelines.